These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Antidepressant use in treatment of psychosis with comorbid depression in Parkinson's disease. Meco G; Bernardi S Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):311-3. PubMed ID: 16919377 [TBL] [Abstract][Full Text] [Related]
4. Long-term evaluation of the effect of quetiapine on hallucinations, delusions and motor function in advanced Parkinson disease. Mancini F; Tassorelli C; Martignoni E; Moglia A; Nappi G; Cristina S; Pacchetti C Clin Neuropharmacol; 2004; 27(1):33-7. PubMed ID: 15090935 [TBL] [Abstract][Full Text] [Related]
5. Rater-blinded, prospective comparison: quetiapine versus clozapine for Parkinson's disease psychosis. Merims D; Balas M; Peretz C; Shabtai H; Giladi N Clin Neuropharmacol; 2006; 29(6):331-7. PubMed ID: 17095896 [TBL] [Abstract][Full Text] [Related]
6. Management of hallucinations and psychosis in Parkinson's disease. Eng ML; Welty TE Am J Geriatr Pharmacother; 2010 Aug; 8(4):316-30. PubMed ID: 20869621 [TBL] [Abstract][Full Text] [Related]
8. Atypical antipsychotic drugs in the treatment of Parkinson's disease. Friedman JH J Pharm Pract; 2011 Dec; 24(6):534-40. PubMed ID: 22095576 [TBL] [Abstract][Full Text] [Related]
9. Current Understanding of Psychosis in Parkinson's Disease. Ojo OO; Fernandez HH Curr Psychiatry Rep; 2016 Oct; 18(10):97. PubMed ID: 27629356 [TBL] [Abstract][Full Text] [Related]
10. Quetiapine and clozapine in parkinsonian patients with dopaminergic psychosis. Morgante L; Epifanio A; Spina E; Zappia M; Di Rosa AE; Marconi R; Basile G; Di Raimondo G; La Spina P; Quattrone A Clin Neuropharmacol; 2004; 27(4):153-6. PubMed ID: 15319699 [TBL] [Abstract][Full Text] [Related]
11. Mirtazapine improves visual hallucinations in Parkinson's disease: a case report. Tagai K; Nagata T; Shinagawa S; Tsuno N; Ozone M; Nakayama K Psychogeriatrics; 2013 Jun; 13(2):103-7. PubMed ID: 23909968 [TBL] [Abstract][Full Text] [Related]
12. Quetiapine improves visual hallucinations in Parkinson disease but not through normalization of sleep architecture: results from a double-blind clinical-polysomnography study. Fernandez HH; Okun MS; Rodriguez RL; Malaty IA; Romrell J; Sun A; Wu SS; Pillarisetty S; Nyathappa A; Eisenschenk S Int J Neurosci; 2009; 119(12):2196-205. PubMed ID: 19916848 [TBL] [Abstract][Full Text] [Related]
13. A possible case of peduncular hallucinosis in a patient with Parkinson's disease successfully treated with quetiapine. Spiegel DR; Lybeck B; Angeles V J Neuropsychiatry Clin Neurosci; 2009; 21(2):225-6. PubMed ID: 19622697 [No Abstract] [Full Text] [Related]
14. Hallucinations and psychosis in Parkinson's disease. Rabey JM Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 4():S105-10. PubMed ID: 20123547 [TBL] [Abstract][Full Text] [Related]
15. Quetiapine-Induced extrapyramidal side effects in patients with Parkinson's disease: case report. Sommer BR J Geriatr Psychiatry Neurol; 2001; 14(2):99-100. PubMed ID: 11419575 [TBL] [Abstract][Full Text] [Related]